Study Stopped
See termination reason in detailed description.
Comparative Trial Of Maraviroc Versus Emtricitabine/Tenofovir Both With Darunavir/Ritonavir In Antiretroviral-Naive Patients Infected With CCR5 Tropic HIV 1
MODERN
A Multicenter, Randomized, Double-Blind, Comparative Trial Of Maraviroc + Darunavir/Ritonavir Versus Emtricitabine/Tenofovir + Darunavir/Ritonavir For The Treatment Of Antiretroviral-Naive Hiv-Infected Patients With Ccr5-Tropic Hiv-1
2 other identifiers
interventional
813
18 countries
170
Brief Summary
The purpose of this study is to assess whether maraviroc administered once daily is non-inferior to emtricitabine/tenofovir also administered once daily each in combination with darunavir/ritonavir in the treatment of antiretroviral-naive patients as evaluated at Week 48 of treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_3
Started Sep 2011
170 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 27, 2011
CompletedFirst Posted
Study publicly available on registry
May 2, 2011
CompletedStudy Start
First participant enrolled
September 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2014
CompletedResults Posted
Study results publicly available
January 14, 2016
CompletedJanuary 14, 2016
December 1, 2015
1.9 years
April 27, 2011
August 14, 2014
December 11, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Percentage of Participants With Plasma HIV-1 RNA <50 Copies/mL.
The proportion of participants who achieved HIV-1 RNA \<50 copies/mL at week 48 was assessed according to Food and Drug Administration's (FDA's) Missing, Switch, Discontinuation'=Failure (MSDF) Snapshot algorithm. The algorithm used the plasma HIV-1 RNA in the Week 48 visit window, followed the "virology-first principle" and considers a participant who has a missing plasma HIV-1 RNA, or switches to prohibited ARV regimen or discontinues from the study or study drug for any reason, or dies, as a failure.
Week 48
Secondary Outcomes (24)
Frequency of Adverse Events (AE).
Week 96
Number of Participants With Grade 3 or 4 AEs
Week 96
Number of Participants Who Discontinued Due to AEs
Week 96
Number of Treatment-related AEs
Week 96
Number of Participants With Treatment-emergent Serious Adverse Events
Week 96
- +19 more secondary outcomes
Study Arms (2)
Maraviroc
EXPERIMENTALMaraviroc 150 mg once daily plus darunavir/ritonavir 800/100 mg once daily plus placebo for emtricitabine/tenofovir once daily.
Emtricitabine/tenofovir
ACTIVE COMPARATOREmtricitabine/tenofovir 200/300 mg once daily plus darunavir/ritonavir 800/100 mg once daily plus placebo for maraviroc once daily.
Interventions
Maraviroc tablet 150 mg once daily for 96 weeks.
Emtricitabine/tenofovir tablet 200/300 mg once daily for 96 weeks.
placebo for emtricitabine/tenofovir
Eligibility Criteria
You may qualify if:
- Plasma HIV-1 RNA equal to or greater than 1,000 copies/mL measured at the Screening Visit.
- CD4 count equal to or greater than 100 cells/mm3 at Screening.
- Have only R5 HIV 1 at Screening as verified by a randomized tropism assay.
You may not qualify if:
- Prior treatment with any other HIV antiretroviral therapy for more than 14 days at any time.
- Any evidence of genotypic/phenotypic resistance to darunavir, tenofovir, and emtricitabine.
- CXCR4 using virus detected using randomized tropism determination or repeated failure to obtain an interpretable tropism result.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- ViiV Healthcarelead
- Pfizercollaborator
Study Sites (177)
University of Alabama at Birmingham - 1917 Research Clinic
Birmingham, Alabama, 35294, United States
Health Services Center
Hobson City, Alabama, 36201, United States
Kaiser Permanente
Hayward, California, 94545, United States
Cedars-Sinai Medical Center
Los Angeles, California, 90048, United States
Dr. Anthony Mills, MD, Inc.
Los Angeles, California, 90069, United States
Orange Coast Medical Group
Newport Beach, California, 92663, United States
Desert Oasis Healthcare Medical Group
Palm Springs, California, 92262, United States
University of California Davis Research
Sacramento, California, 95814, United States
TICON I Research Clinic (DEXA Scan only)
Sacramento, California, 95817, United States
Kaiser Hospital Sacramento
Sacramento, California, 95825, United States
Synarc Inc.
San Francisco, California, 94105, United States
Investigational Drugs Pharmacy
San Francisco, California, 94118, United States
Kaiser Permanente - Clinical Trials Unit
San Francisco, California, 94118, United States
Kaiser Permanente Santa Clara
Santa Clara, California, 95051, United States
Kaiser Permanente
Union City, California, 94587, United States
University of Colorado Denver - University of Colorado Hospital
Aurora, Colorado, 80045, United States
Kaiser Permanente of Colorado
Denver, Colorado, 80205, United States
Yale - New Haven Hospital Nathan Smith Clinic
New Haven, Connecticut, 06504, United States
Yale University
New Haven, Connecticut, 06510, United States
Circle CARE Center
Norwalk, Connecticut, 06851, United States
Capital Medical Associates, PC
Washington D.C., District of Columbia, 20036, United States
George Washington University Medical Faculty Associates
Washington D.C., District of Columbia, 20037, United States
Broward Health - Comprehensive Care Center
Fort Lauderdale, Florida, 33311, United States
Broward General Medical Center
Fort Lauderdale, Florida, 33316, United States
The Kinder Medical Group
Miami, Florida, 33133, United States
UMHC/Sylvester Comprehensive Cancer Center
Miami, Florida, 33136, United States
University of Miami AIDS Clinical Research Unit
Miami, Florida, 33136, United States
University of Miami
Miami, Florida, 33136, United States
Community AIDS Resource Inc dba Care Resource
Miami, Florida, 33137, United States
Miami Research Associates
Miami, Florida, 33143, United States
Wohlfeiler, Piperato and Associates, LLC
Miami Beach, Florida, 33139, United States
Infectious Diseases Associates of Northwest Florida, PA
Pensacola, Florida, 32504, United States
St. Joseph's Hospital Diagnostic Center
Tampa, Florida, 33067, United States
University of South Florida Health-HIV Clinical Research Unit
Tampa, Florida, 33602, United States
Infectious Disease Research Institute, Inc.
Tampa, Florida, 33614, United States
Osteoporosis Care Center
Tampa, Florida, 33614, United States
Quest Diagnostic Laboratory
Tampa, Florida, 33614, United States
Rowan Tree Medical, PA
Wilton Manors, Florida, 33305, United States
AIDS Research Consortium of Atlanta
Atlanta, Georgia, 30312, United States
DeKalb Medical Diagnostic Breast Center
Decatur, Georgia, 30033, United States
Infectious Disease Specialists of Atlanta
Decatur, Georgia, 30033, United States
Northwestern University/NMH
Chicago, Illinois, 60611, United States
Northwestern University
Chicago, Illinois, 60611, United States
Howard Brown Health Center
Chicago, Illinois, 60613, United States
University of Iowa, University of Hospitals and Clinics - Division of Infectious Disease
Iowa City, Iowa, 52242, United States
Tulane University School of Medicine
New Orleans, Louisiana, 70112, United States
Ochsner Clinic Foundation
New Orleans, Louisiana, 70121, United States
Baystate Infectious Diseases Clinical Research
Springfield, Massachusetts, 01199, United States
Be Well Medical Center, PC
Berkley, Michigan, 48072, United States
University Physicians Group
Detroit, Michigan, 48201, United States
Wayne State University
Detroit, Michigan, 48201, United States
Henry Ford Health System
Detroit, Michigan, 48202, United States
Michigan State University College of Osteopathic Medicine - Department of Internal Medicine
East Lansing, Michigan, 48824, United States
Biomedical and Health Institutional Review Board
East Lansing, Michigan, 48825, United States
Ingham County Health Department
Lansing, Michigan, 48911, United States
Hennepin County Medical Center
Minneapolis, Minnesota, 55415, United States
Kansas City Free Health Clinic
Kansas City, Missouri, 64111, United States
University of Nebraska Medical Center
Omaha, Nebraska, 68106, United States
Jersey Shore University Medical Center
Neptune City, New Jersey, 07753, United States
Brandywine Common
Neptune City, New Jersey, 07754, United States
Jersey Shore University Medical Center
Neptune City, New Jersey, 07754, United States
Saint Michael's Medical Center
Newark, New Jersey, 07102, United States
Erie County Medical Center
Buffalo, New York, 14215, United States
Beth Israel Medical Center - AIDS Clinical Trials Unit
New York, New York, 10003, United States
AIDS Community Research Initiative of America (ACRIA)
New York, New York, 10018, United States
Research Across America
New York, New York, 10022, United States
Dr. Howard A. Grossman, M.D.
New York, New York, 10107, United States
AIDS Care
Rochester, New York, 14607, United States
New York Medical College
Valhalla, New York, 10595, United States
I.D. Consultants, P.A.
Charlotte, North Carolina, 28209, United States
(DEXA Scan Facility) East Carolina University Brody Outpatient Center
Greenville, North Carolina, 27834, United States
East Carolina University Division of Infectious Diseases
Greenville, North Carolina, 27834, United States
University of Cincinnati - Department of Internal Medicine
Cincinnati, Ohio, 45267, United States
The University of Toledo Medical Center
Toledo, Ohio, 43614, United States
Central Texas Clinical Research
Austin, Texas, 78705, United States
Dallas Diabetes and Endocrine Center
Dallas, Texas, 75230, United States
Parkland Memorial Hospital
Dallas, Texas, 75235, United States
University of Texas Southwestern Medical Center at Dallas
Dallas, Texas, 75235, United States
North Texas Infectious Diseases Consultants, PA
Dallas, Texas, 75246, United States
Therapeutic Concepts, PA
Houston, Texas, 77004, United States
Research Access Network
Houston, Texas, 77098, United States
The Office of Dr. Gordon E. Crofoot, M.D., PA
Houston, Texas, 77098, United States
Swedish Medical Center
Seattle, Washington, 98104, United States
Swedish Medical Center
Seattle, Washington, 98122, United States
East Sydney Doctors
Darlinghurst, New South Wales, 2010, Australia
Holdsworth House General Practice
Darlinghurst, New South Wales, 2010, Australia
St Vincent's Hospital
Darlinghurst, New South Wales, 2010, Australia
Taylor Square Private Clinic
Surry Hills, New South Wales, 2010, Australia
Brisbane Sexual Health and HIV Service
Brisbane, Queensland, 4000, Australia
Melbourne Sexual Health Centre
Carlton, Victoria, 3053, Australia
Clinical Research Unit, Infectious Diseases
Melbourne, Victoria, 3004, Australia
AKH Wien Universitaetsklinik fuer Dermatologie
Vienna, 1090, Austria
Instituut voor Tropische Geneeskunde
Antwerp, B-2000, Belgium
C.H.U. St-Pierre
Brussels, 1000, Belgium
Hôpital Universitaire Erasme
Brussels, 1070, Belgium
Cliniques Universitaires St-Luc
Brussels, 1200, Belgium
Universitair Ziekenhuis Gent
Ghent, B-9000, Belgium
C.H.U. Sart-Tilman
Liège, 4000, Belgium
Vancouver ID Research and Care Centre Society
Vancouver, British Columbia, V6Z 2C7, Canada
The Ottawa Hospital-Riverside Campus
Ottawa, Ontario, K1H 7W9, Canada
The Ottawa Hospital
Ottawa, Ontario, K1H 8L6, Canada
Maple Leaf Research / Maple Leaf Medical Clinic
Toronto, Ontario, M5G 1K2, Canada
University Health Network / Toronto General Hospital
Toronto, Ontario, M5G 2N2, Canada
Clinique Medicale L'Actuel
Montreal, Quebec, H2L 4P9, Canada
Clinique Medicale du Quartier Latin
Montreal, Quebec, H2L 5B1, Canada
Hvidovre Hospital, Infektionsmedicinsk afd.
Hvidovre, 2650, Denmark
Rigshospitalet, Epidemiklinikken
Koebenhavn OE, 2100, Denmark
Odense Universitetshospital
Odense, 5000, Denmark
Infektiosairauksien poliklinikka,HUS Auroran sairaala, rakennus 5, 1. krs
Helsinki, 00250, Finland
CHR d'Orleans la Source
Orléans, Cedex 02, 45067, France
Hopital Saint Antoine
Paris, Cedex 12, 75571, France
Hopital Bichat
Paris, Cedex 18, 75877, France
Hopital Saint-andre
Bordeaux, France, 33075, France
Hopital Henri Mondor
Créteil, 94000, France
Hopital Bicetre
Le Kremlin-Bicêtre, 94275, France
Hopital de la Croix Rousse
Lyon, 69317, France
Hopital Gui de Chauliac
Montpellier, 34295, France
CHU de Nantes - Hotel Dieu
Nantes, 44035, France
Hôpital de la Pitié Salpétrière
Paris, 75013, France
Hopital Tenon, Service des Maladies Infectieuses
Paris, 75020, France
Hopital Saint-Louis
Paris, 75475, France
Nouvel Hopital Civil
Strasbourg, 67091, France
Centre Hospitalier de Tourcoing
Tourcoing, 59208, France
Praxis Christiane Cordes
Berlin, 10243, Germany
Studiengesellschaft mbH Gubener 37
Berlin, 10243, Germany
EPIMED - Gesellschaft fuer epidemiologische und klinische Forschung in der Medizin mbH
Berlin, 12157, Germany
Universitaetsklinikum Bonn, Immunologische Ambulanz HIV
Bonn, 53127, Germany
Klinikum der Universitaet zu Koeln, Klinik I fuer Innere Medizin
Cologne, 50937, Germany
Klinikum der J.W. Goethe-Universitaet, Medizinische Klinik II
Frankfurt am Main, 60590, Germany
InfektioResearch GmbH & Co. KG
Frankfurt am Main, 60596, Germany
ifi - Studien und Projekte GmbH
Hamburg, 20099, Germany
ICH - Study - Center GmbH & Co. KG
Hamburg, 20146, Germany
Universitaetsklinikum Hamburg-Eppendorf
Hamburg, 20246, Germany
MUC Research Group GbR
München, 80335, Germany
Ludwig-Maximilians-Universitaet, Medizinische Poliklinik - Klinikum Innenstadt
München, 80336, Germany
Egyesitett Szent Istvan és Szent Laszlo Korhaz-Rendelointezet
Budapest, 1097, Hungary
Ospedale San Raffaele
Milan, 20127, Italy
University Medical Center Utrecht
Utrecht, 3584 CX, Netherlands
Wojewodzki Szpital Obserwacyjno - Zakazny im. Tadeusza Browicza
Bydgoszcz, 85-030, Poland
SPZOZ Wojewodzki Szpital Zakazny
Warsaw, 01-201, Poland
EMC Instytut Medyczny S.A. Przychodnia przy ul. Lowieckiej
Wroclaw, 50-220, Poland
Hospital Prof. Doutor Fernando Fonseca E.P.E.
Amadora, Portugal, 2720-276, Portugal
Centro Hospitalar de Lisboa - Zona Central - Hospital Santo António Capuchos
Lisbon, 1169-050, Portugal
Hospital Sta. Maria
Lisbon, 1649-035, Portugal
Hospital São João
Porto, 4200-319, Portugal
Innovative Care PSC
Bayamón, PR, 00959, Puerto Rico
Ararat Research Center
Ponce, PR, 00717, Puerto Rico
Medical Center University Hospital
Rio Piedras, PR, 00935, Puerto Rico
Clinical Research Puerto Rico
San Juan, PR, 00909, Puerto Rico
HOPE Clinical Research
San Juan, PR, 00909, Puerto Rico
University of Puerto Rico Medical Sciences Campus
Rio Piedras, 00935, Puerto Rico
Hospital General Universitario de Alicante
Alicante, Alicante, 03010, Spain
Hospital del Mar
Barcelona, Barcelona, 08003, Spain
Hospital de la Santa Creu i Sant Pau
Barcelona, Barcelona, 08025, Spain
Hospital Clinic I Provincial de Barcelona
Barcelona, Barcelona, 08036, Spain
Hospital Universitari de Bellvitge
L'Hospitalet de Llobregat, Barcelona, 08907, Spain
Hospital Universitario Reina Sofia - Hospital Provincial
Córdoba, Cordoba, 14004, Spain
Hospital General Universitario Gregorio Marañon
Madrid, Madrid, 28007, Spain
Hospital Universitario de La Paz
Madrid, Madrid, 28046, Spain
Hospital Universitario Virgen de la Macarena
Seville, Sevilla, 41007, Spain
SU Ostra sjukhuset, Infektionsmottagningen
Gothenburg, 416 85, Sweden
Skanes Universitetssjukhus
Malmo, 205 02, Sweden
Sodersjukhuset, Venhalsan
Stockholm, 118 83, Sweden
Karolinska Universitetssjukhuset Huddinge
Stockholm, 141 86, Sweden
Universitaetsspital Basel Infektiologie und Spitalhygiene
Basel, 4031, Switzerland
Inselspital Universitaetsklinik fuer Infektiologie
Bern, 3010, Switzerland
Kantonsspital St. Gallen
Sankt Gallen, 9007, Switzerland
Universitatsspital Zurich
Zurich, 8091, Switzerland
Dept of Sexual Health & HIV Medicine
Birmingham, B9 5SS, United Kingdom
HIV Research Department, Elton John Centre
Brighton, BN2 1ES, United Kingdom
Regional Infectious Diseases Unit
Edinburgh, EH4 2XU, United Kingdom
Grahame Hayton Unit, Ambrose King Centre, Royal London Hospital,
London, E1 1BB, United Kingdom
Ian Charleson Day Centre, Royal Free Hospital
London, NW3 2QG, United Kingdom
Queen Elizabeth Hospital
London, SE18 4QH, United Kingdom
St Stephen's Centre, Chelsea and Westminster Hospital NHS Foundation Trust
London, SW10 9NH, United Kingdom
Centre for Sexual Health & HIV Research, University College London
London, WC1E 6AU, United Kingdom
Department of Infectious Diseases & Tropical Medicine, Pennine Acute Trust Hospitals
Manchester, M8 5RB, United Kingdom
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Limitations and Caveats
The study was terminated following a preliminary review of the 48- week primary clinical efficacy data by the study's external independent Data Monitoring Committee's recommendation based on inferior efficacy of the investigational MVC+DRV/r arm.
Results Point of Contact
- Title
- Pfizer ClinicalTrials.gov Call Center
- Organization
- Pfizer, Inc.
Study Officials
- STUDY DIRECTOR
Pfizer CT.gov Call Center
Pfizer
Publication Agreements
- PI is Sponsor Employee
- No
- Restriction Type
- OTHER
- Restrictive Agreement
- Yes
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 27, 2011
First Posted
May 2, 2011
Study Start
September 1, 2011
Primary Completion
August 1, 2013
Study Completion
January 1, 2014
Last Updated
January 14, 2016
Results First Posted
January 14, 2016
Record last verified: 2015-12